A week or so ago I asked a question about how insitutions handled residual balances after the conclusion of company-sponsored clinical trials.  I received a number of responses to this question and I promised to share them with the group.  I have posted the responses (stripped of institutional identifiers) on my office's website at the following URL: <http://www.mco.edu/research/residual_balances.pdf>.  I will leave the file on the website for about 2 weeks, then remove it.

BTW, I would like to suggest this mechanism for distributing all binary files to members of this group, i.e., just post the file to your website and give everyone the URL via e-mail.  There appear to be at least 2 advantages to doing it this way:  1)  It keeps down the size of messages; and 2)  the files are easily available to all.  Those of us who receive RESADM-L in the Digest format do not receive binary attachments in a usable form (they get "dumped" into the regular message text in an unusable format).

doug

Doug Wilkerson, Ph.D.              Phone:   (419) 383-4252
Assoc. V.P. For Research          Fax:   (419) 383-4252
Professor of Pharmacology         E-mail:   xxxxxx@mco.edu
Research & Grants Admin.          Web: www.mco.edu/research
Block Health Sci. Bldg., Rm. 148
3035 Arlington Ave.
Toledo, OH 43614-5804

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================